Reporting in the journal   researchers say a new method for essentially resetting the immune systems of patients with multiple sclerosis appears to be safe Study coauthor Stephen D Miller of Northwestern University describes the novel approach tested in this small phase  clinical trial and explains how it might one day also be used to treat other autoimmune diseases such as type  diabetes